<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.116403</article-id><article-id pub-id-type="publisher-id">ACM-43351</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210600000_48484536.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  杨氏模量值与BMP-7在糖尿病肾病不同分期诊断中的意义
  Significance of Young’s Modulus and BMP-7 in the Diagnosis of Different Stages of Diabetic Nephropathy
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>靓</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>宋</surname><given-names>瓅</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>马</surname><given-names>蕾媛</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邵</surname><given-names>长杰</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>于</surname><given-names>宁</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛大学附属医院，运动医学科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>青岛大学附属医院，腹部超声科，山东 青岛</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>06</month><year>2021</year></pub-date><volume>11</volume><issue>06</issue><fpage>2781</fpage><lpage>2787</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  目的：探讨剪切波弹性成像技术所测的杨氏模量值与肾组织中BMP-7在不同分期糖尿病肾病的诊断意义。方法：选自2018年9月至2020年10月我院糖尿病肾病患者91例，根据尿微量白蛋白排泄率分为3组：正常白蛋白尿组38人；早期糖尿病肾病组29人；临床糖尿病肾病组24人。对照组取自正常志愿者34例。采集所有受检者肾组织的收缩期峰值流速(peak systolic velocity, PSV)、舒张末期流速(end diastolic velocity, EDV)、血管阻力指数(resistance index, RI)、血管搏动指数(pulsatility index, PI)、杨氏模量值(Young’s modulus, E)，将所有糖尿病肾病受检者活检所取得的肾组织制成切片，并计算出BMP-7的含量。分析BMP-7与E值的关系。结果：1) 与对照组相比，糖尿病肾病组的E值差异具有统计学意义。随着糖尿病肾病的病情发展E值逐渐增高，而BMP-7逐渐降低；2) E与BMP-7的相关系数为−0.655；3) 根据ROC结果提示，E值在对照组与A组比较时，P &gt; 0.05，而E与BMP-7在A/B、B/C组别时(P &lt; 0.05)的截断值分别为4.9、5.8和172.3、114.1。结论：BMP-7与E成明显负相关，且在早期糖尿病肾病和临床糖尿病肾病中，BMP-7与E有很好的诊断效益。
   Objective: To explore the diagnostic significance of Young’s modulus measured by shear wave elastography and BMP-7 in renal tissue in different stages of diabetic nephropathy. Methods: 91 patients with diabetic nephropathy were selected in our hospital from September 2018 to October 2020. According to urinary microalbumin excretion rate, they were divided into 3 groups: 38 patients in the normal albuminuria group, 29 patients in the early diabetic nephropathy group, clinical diabetic nephropathy group of 24 patients. The control group was recruited from 34 normal volunteers. Peak Systolic Velocity (PSV), End Diastolic Velocity (EDV), Resistance Index (RI), Pulsatility Index (PI), Young’s modulus (E) were collected from all renal tissues of the subjects. The renal tissue from the biopsy of the subject was made into sections and the content of BMP-7 was calculated. The relationship between BMP-7 and E value was analyzed. Results: 1) Compared with the control group, the difference of BMP-7 and E value in diabetic nephropathy group was statistically significant. With the development of diabetic nephropathy, E value increased gradually, while BMP-7 decreased gradually; 2) The correlation coefficient between E and BMP-7 is −0.655; 3) According to the ROC results, when E was compared between the control group and the A group, P &gt; 0.05, while in the A/B and B/C groups (P &lt; 0.05), the cut-off values of E and BMP-7 were respectively 4.9, 5.8 and 172.3, 114.1. Conclusion: BMP-7 is negatively correlated with E, and BMP-7 and E have a good diagnostic benefit in early diabetic nephropathy and clinical diabetic nephropathy.
 
</p></abstract><kwd-group><kwd>糖尿病肾病，骨形态发生蛋白7，剪切波弹性成像技术，杨氏模量值, Diabetic Nephropathy</kwd><kwd> Bone Morphogenetic Protein 7</kwd><kwd> Shear Wave Elastography</kwd><kwd> Young’s Modulus Value</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：探讨剪切波弹性成像技术所测的杨氏模量值与肾组织中BMP-7在不同分期糖尿病肾病的诊断意义。方法：选自2018年9月至2020年10月我院糖尿病肾病患者91例，根据尿微量白蛋白排泄率分为3组：正常白蛋白尿组38人；早期糖尿病肾病组29人；临床糖尿病肾病组24人。对照组取自正常志愿者34例。采集所有受检者肾组织的收缩期峰值流速(peak systolic velocity, PSV)、舒张末期流速(end diastolic velocity, EDV)、血管阻力指数(resistance index, RI)、血管搏动指数(pulsatility index, PI)、杨氏模量值(Young’s modulus, E)，将所有糖尿病肾病受检者活检所取得的肾组织制成切片，并计算出BMP-7的含量。分析BMP-7与E值的关系。结果：1) 与对照组相比，糖尿病肾病组的E值差异具有统计学意义。随着糖尿病肾病的病情发展E值逐渐增高，而BMP-7逐渐降低；2) E与BMP-7的相关系数为−0.655；3) 根据ROC结果提示，E值在对照组与A组比较时，P &gt; 0.05，而E与BMP-7在A/B、B/C组别时(P &lt; 0.05)的截断值分别为4.9、5.8和172.3、114.1。结论：BMP-7与E成明显负相关，且在早期糖尿病肾病和临床糖尿病肾病中，BMP-7与E有很好的诊断效益。</p></sec><sec id="s2"><title>关键词</title><p>糖尿病肾病，骨形态发生蛋白7，剪切波弹性成像技术，杨氏模量值</p></sec><sec id="s3"><title>Significance of Young’s Modulus and BMP-7 in the Diagnosis of Different Stages of Diabetic Nephropathy<sup> </sup></title><p>Liang Zhang<sup>1</sup>, Li Song<sup>2</sup>, Leiyuan Ma<sup>1</sup>, Changjie Shao<sup>1</sup>, Ning Yu<sup>1*</sup></p><p><sup>1</sup>Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Department of Sports Medicine, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/45-1572337x5_hanspub.png" /></p><p>Received: May 17<sup>th</sup>, 2021; accepted: Jun. 3<sup>rd</sup>, 2021; published: Jun. 24<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/45-1572337x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To explore the diagnostic significance of Young’s modulus measured by shear wave elastography and BMP-7 in renal tissue in different stages of diabetic nephropathy. Methods: 91 patients with diabetic nephropathy were selected in our hospital from September 2018 to October 2020. According to urinary microalbumin excretion rate, they were divided into 3 groups: 38 patients in the normal albuminuria group, 29 patients in the early diabetic nephropathy group, clinical diabetic nephropathy group of 24 patients. The control group was recruited from 34 normal volunteers. Peak Systolic Velocity (PSV), End Diastolic Velocity (EDV), Resistance Index (RI), Pulsatility Index (PI), Young’s modulus (E) were collected from all renal tissues of the subjects. The renal tissue from the biopsy of the subject was made into sections and the content of BMP-7 was calculated. The relationship between BMP-7 and E value was analyzed. Results: 1) Compared with the control group, the difference of BMP-7 and E value in diabetic nephropathy group was statistically significant. With the development of diabetic nephropathy, E value increased gradually, while BMP-7 decreased gradually; 2) The correlation coefficient between E and BMP-7 is −0.655; 3) According to the ROC results, when E was compared between the control group and the A group, P &gt; 0.05, while in the A/B and B/C groups (P &lt; 0.05), the cut-off values of E and BMP-7 were respectively 4.9, 5.8 and 172.3, 114.1. Conclusion: BMP-7 is negatively correlated with E, and BMP-7 and E have a good diagnostic benefit in early diabetic nephropathy and clinical diabetic nephropathy.</p><p>Keywords:Diabetic Nephropathy, Bone Morphogenetic Protein 7, Shear Wave Elastography, Young’s Modulus Value</p><disp-formula id="hanspub.43351-formula56"><graphic xlink:href="//html.hanspub.org/file/45-1572337x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/45-1572337x8_hanspub.png" /> <img src="//html.hanspub.org/file/45-1572337x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>随着人们生活质量及生活水平的提高，糖尿病的发病率也逐年提高，糖尿病也引起越来越多人的注意，当进展到晚期，影响了大部分糖尿病患者的肾脏功能，即肾组织的微血管发生了一系列的改变，由糖尿病作为基础病并引起肾组织微血管改变的疾病即为糖尿病肾病(diabetic nephropathy, DN) [<xref ref-type="bibr" rid="hanspub.43351-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref2">2</xref>]。同其它慢性肾脏病，DN会通过肾小球硬化及肾间质纤维化过程最终进展为肾衰竭，影响着糖尿病患者们的预后。研究发现，骨形态发生蛋白(bone morphogenetic protein, BMP)也参与肾脏的发生与发展过程 [<xref ref-type="bibr" rid="hanspub.43351-ref3">3</xref>]。BMP-7与转化生长因子β (transforming growth factor-β, TGF-β)对肾脏表现为拮抗作用，TGF-β为促纤维化因子 [<xref ref-type="bibr" rid="hanspub.43351-ref4">4</xref>]，而BMP-7通过抑制纤维化的进程，对肾脏起着保护作用。剪切波弹性成像技术(shear wave elastography, SWE)通过对剪切波波速的测定，进一步直观地得出所测组织杨氏模量值(Young’s modulus, E)，杨氏模量值即为所测组织的硬度值 [<xref ref-type="bibr" rid="hanspub.43351-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref6">6</xref>]。故本文采用SWE技术对糖尿病肾病患者的肾组织进行测量，用E反应肾组织的硬度，并将该处肾组织的BMP-7的表达量进行计算，探讨E与糖尿病肾病患者表达的BMP-7的关系，并研究E与BMP-7对于不同分期的糖尿病肾病的诊断意义。</p></sec><sec id="s6"><title>2. 一般资料</title><sec id="s6_1"><title>2.1. 研究对象</title><p>研究对象取自2018年9月至2020年10月因糖尿病肾病入住我院的患者91人，其中男性59人，女性32人，平均年龄56.7 &#177; 12.4岁，纳入标准：所有研究对象均符合1999年由世界卫生组织认定的糖尿病肾病诊断标准；均自愿做泌尿系统的肾脏检查，并且行肾脏穿刺，病理结果已归；临床检验结果完善。排除标准：有其他影响肾脏功能的疾病。</p><p>由于本研究需对糖尿病肾病以及对照组肾组织的BMP-7的含量进行探究，故需要对实验组以及对照组进行肾穿刺，获得病理结果后进行下一步研究。肾穿刺为有创操作，对照组若选择正常人则不符合医学伦理学的要求，故本研究中的对照组选自同期未患有肾脏疾病的正常志愿者34例，对受检者均行超声检查，但并未行肾穿刺操作，故对照组的BMP-7的结果缺失。本研究经过医院伦理委员会审核通过，所有受试者均获得知情同意。</p><p>根据24 h尿白蛋白定量将研究对象分为A组：正常白蛋白尿组，尿微量白蛋白排泄率 &lt; 20 μg/min患者38人，平均年龄52.9 &#177; 10.3岁；B组：早期糖尿病肾病组，20 μg/min ≤ 尿微量白蛋白排泄率 ≤ 200 μg/min患者29人，平均年龄58.7 &#177; 13.9岁；C组：临床糖尿病肾病组：尿微量白蛋白排泄率 &gt; 200 μg/min患者24人，平均年龄57.9 &#177; 11.4岁。</p></sec><sec id="s6_2"><title>2.2. 研究方法</title><sec id="s6_2_1"><title>2.2.1. 临床资料</title><p>将所有纳入研究的对象的年龄、糖尿病病程、BMI以及尿微量白蛋白排泄率进行记录。</p></sec><sec id="s6_2_2"><title>2.2.2. 超声检查方法</title><p>本研究使用的法国声科影像(SuperSonic Imagine)的超声诊断系统，对研究对象的肾组织进行普通B超检查和E成像。探头选用凸阵SC6-1，设定频率为3~5 MHz，嘱被检查者右侧卧位于检查床，充分暴露左腰部，涂抹耦合剂后，即可配合患者的呼吸进行肾脏组织的扫查，需测量检查者的肾脏叶间动脉的收缩期峰值流速(peak systolic velocity, PSV)、舒张末期流速(end diastolic velocity, EDV)、血管阻力指数(resistance index, RI)、血管搏动指数(pulsatility index, PI)。待探头发出的声束与肾脏长轴垂直时，打开“SWE”模式，嘱被检查者屏气，选取肾脏中下极为感兴趣区，待图像稳定后，即可测量出该区域的肾组织的杨氏模量值即Emean，重复三次测量后取平均值(如图1所示)。</p></sec><sec id="s6_2_3"><title>2.2.3. 肾脏穿刺活检</title><p>选用3代穿刺枪，型号为18G的穿刺针，根据实际情况设定穿刺射程。常规超声检查后，确定肾脏穿刺部位同超声检查的感兴趣区一致，消毒铺巾，在利多卡因局部麻醉下，进针，将取得的肾组织用石蜡固定。</p></sec><sec id="s6_2_4"><title>2.2.4. 免疫组化因子BMP-7的获取方法</title><p>对切片进行HE及Massion染色，在显微镜下观察肾组织的病理改变情况，如肾小球硬化、肾间质纤维化等。脱水、包埋后制成4 μm的石蜡切片，采用envision免疫组化二步法对切片染色，选取含有完整肾小球、肾小管的组织切片在&#215;400倍的显微镜下进行观察，棕黄色区域即为BMP-7因子沉积，采用image pro plus 6.0 (IPP)进行阳性面积的计算，用平均密度值(Mean Density)表示BMP-7的含量。其中，制成的切片要避免气泡与褶皱，IPP计算出的结果需测量三次后取平均值。</p><p>图1. (a) 在对照组中测量E的图像；(b) 在A组中测量E的图像；(c) 在B组中测量E的图像；(d) 在C组中测量E的图像</p></sec></sec><sec id="s6_3"><title>2.3. 统计学方法</title><p>采用SPSS v26将符合正态分布的参数进行组间差异性统计学分析，结果用中位数(上下四分位数)表示。各参数之间的相关性用Spearman进行分析，用Medcalc绘制E、BMP-7的ROC曲线，以上均认为P &lt; 0.05差异具有统计学意义。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 临床资料统计结果</title><p>将四组对象的年龄、病程、BMI、BMP-7、Emean、UAER、PSV、EDV、RI、PI数据进行统计，具体数据见表1。</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Baseline data of clien</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >指标</th><th align="center" valign="middle" >对照组</th><th align="center" valign="middle" >A组</th><th align="center" valign="middle" >B组</th><th align="center" valign="middle" >C组</th><th align="center" valign="middle" >t值</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >例数</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >年龄(岁)</td><td align="center" valign="middle" >51.00 (41.75, 56.25)</td><td align="center" valign="middle" >52.00 (46.75, 60.50)</td><td align="center" valign="middle" >57.00 (51.00, 73.00)<sup>#</sup></td><td align="center" valign="middle" >56.50 (51.00, 67.50)</td><td align="center" valign="middle" >1.041</td><td align="center" valign="middle" >0.430</td></tr><tr><td align="center" valign="middle" >病程(年)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >6 (4, 8)</td><td align="center" valign="middle" >6 (4, 7.5)</td><td align="center" valign="middle" >7 (5, 9)<sup>$</sup></td><td align="center" valign="middle" >1.213</td><td align="center" valign="middle" >0.284</td></tr><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" >24.30 (22.70, 25.65)</td><td align="center" valign="middle" >24.00 (22.78, 24.73)</td><td align="center" valign="middle" >23.80 (22.65, 25.50)</td><td align="center" valign="middle" >23.75 (22.53, 24.68)</td><td align="center" valign="middle" >0.471</td><td align="center" valign="middle" >0.995</td></tr><tr><td align="center" valign="middle" >BMP-7</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >224.75 (191.80, 311.15)</td><td align="center" valign="middle" >151.40 (132.25, 168.20)<sup>#</sup></td><td align="center" valign="middle" >101.50 (88.88, 111.45)<sup>$</sup></td><td align="center" valign="middle" >2.567</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Emean (kpa)</td><td align="center" valign="middle" >4.05 (3.775, 4.400)</td><td align="center" valign="middle" >4.20 (3.80, 4.63)</td><td align="center" valign="middle" >5.40 (4.55, 5.80)<sup>#</sup></td><td align="center" valign="middle" >6.55 (5.45, 7.00)<sup>$</sup></td><td align="center" valign="middle" >4.233</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >UAER (μg/min)</td><td align="center" valign="middle" >9.00 (8.60, 9.45)</td><td align="center" valign="middle" >13.00 (12.25, 14.35)</td><td align="center" valign="middle" >184.5 (178.7, 192.6)<sup>#</sup></td><td align="center" valign="middle" >242.6 (219.8, 345.9)<sup>$</sup></td><td align="center" valign="middle" >47.736</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >PSV (cm/s)</td><td align="center" valign="middle" >25.265 (24.005, 27.558)</td><td align="center" valign="middle" >27.025 (23.402, 28.063)</td><td align="center" valign="middle" >21.06 (19.33, 22.97)<sup>#</sup></td><td align="center" valign="middle" >21.61 (20.44, 22.40)</td><td align="center" valign="middle" >1.809</td><td align="center" valign="middle" >0.088</td></tr><tr><td align="center" valign="middle" >EDV (cm/s)</td><td align="center" valign="middle" >12.52 (12.02, 13.36)</td><td align="center" valign="middle" >10.39 (9.6, 11.04)*</td><td align="center" valign="middle" >9.01 (8.41, 9.33)<sup>#</sup></td><td align="center" valign="middle" >8.99 (8.52, 9.22)</td><td align="center" valign="middle" >2.574</td><td align="center" valign="middle" >0.008</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >RI</th><th align="center" valign="middle" >0.69 (0.65, 0.72)</th><th align="center" valign="middle" >0.70 (0.65, 0.75)</th><th align="center" valign="middle" >0.72 (0.70, 0.77)<sup>#</sup></th><th align="center" valign="middle" >0.79 (0.76, 0.82)<sup>$</sup></th><th align="center" valign="middle" >3.738</th><th align="center" valign="middle" >0.000</th></tr></thead><tr><td align="center" valign="middle" >PI</td><td align="center" valign="middle" >1.225 (1.188, 1.273)</td><td align="center" valign="middle" >1.535 (1.401, 1.613)*</td><td align="center" valign="middle" >1.68 (1.66, 1.71)<sup>#</sup></td><td align="center" valign="middle" >1.67 (1.64, 1.69)</td><td align="center" valign="middle" >5.558</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap></table-wrap-group><p>表1. 受检者的基线资料</p><p>题注：*代表A组与对照组比较差异具有统计学意义；#代表A组与B组比较差异具有统计学意义；$代表B组与C组比较差异具有统计学意义。</p></sec><sec id="s7_2"><title>3.2. 相关性统计结果</title><p>E与BMP-7的相关系数为−0.655，此时P &lt; 0.05 (双尾)，表示E与BMP-7为负相关，且相关性强(如图2所示)。</p><p>图2. E与BMP-7的相关性探究图像</p></sec><sec id="s7_3"><title>3.3. 受试者工作曲线结果</title><p>绘制对照组与A组的E值ROC曲线(如图3所示)，以及A组与B组、B组与C组的E、BMP-7的ROC曲线如图所示，并将结果记录，结果提示，E值对照组与A组ROC曲线结果P &gt; 0.05，如表2所示。</p><p>图3. (a) 在正常白蛋白尿组与早期糖尿病肾病组中E与BMP-7的ROC曲线；(b) 在早期糖尿病肾病组与临床糖尿病肾病组中E与BMP-7的ROC曲线</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Diagnostic efficacy of E and BMP-7 in diabetic nephropath</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >参数</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >AUC</th><th align="center" valign="middle" >标准误</th><th align="center" valign="middle" >P值</th><th align="center" valign="middle" >敏感度</th><th align="center" valign="middle" >阈值</th><th align="center" valign="middle" >特异度</th><th align="center" valign="middle" >+LR</th><th align="center" valign="middle" >−LR</th><th align="center" valign="middle" >约登指数</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >E</td><td align="center" valign="middle" >对照/A组</td><td align="center" valign="middle" >0.60</td><td align="center" valign="middle" >0.07</td><td align="center" valign="middle" >0.1355</td><td align="center" valign="middle" >55.26</td><td align="center" valign="middle" >4.1</td><td align="center" valign="middle" >67.65</td><td align="center" valign="middle" >1.71</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >0.23</td></tr><tr><td align="center" valign="middle" >A组/B组</td><td align="center" valign="middle" >0.80</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" >&lt;0.0001*</td><td align="center" valign="middle" >65.52</td><td align="center" valign="middle" >4.9</td><td align="center" valign="middle" >89.47</td><td align="center" valign="middle" >6.22</td><td align="center" valign="middle" >0.39</td><td align="center" valign="middle" >0.55</td></tr><tr><td align="center" valign="middle" >B组/ C组</td><td align="center" valign="middle" >0.76</td><td align="center" valign="middle" >0.07</td><td align="center" valign="middle" >0.0002*</td><td align="center" valign="middle" >62.50</td><td align="center" valign="middle" >5.8</td><td align="center" valign="middle" >82.76</td><td align="center" valign="middle" >1.59</td><td align="center" valign="middle" >0.28</td><td align="center" valign="middle" >0.45</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >BMP-7</td><td align="center" valign="middle" >A组/B组</td><td align="center" valign="middle" >0.88</td><td align="center" valign="middle" >0.05</td><td align="center" valign="middle" >&lt;0.0001*</td><td align="center" valign="middle" >86.21</td><td align="center" valign="middle" >172.3</td><td align="center" valign="middle" >89.47</td><td align="center" valign="middle" >8.19</td><td align="center" valign="middle" >0.15</td><td align="center" valign="middle" >0.76</td></tr><tr><td align="center" valign="middle" >B组/ C组</td><td align="center" valign="middle" >0.85</td><td align="center" valign="middle" >0.06</td><td align="center" valign="middle" >&lt;0.0001*</td><td align="center" valign="middle" >83.33</td><td align="center" valign="middle" >114.1</td><td align="center" valign="middle" >82.76</td><td align="center" valign="middle" >4.83</td><td align="center" valign="middle" >0.20</td><td align="center" valign="middle" >0.66</td></tr></tbody></table></table-wrap><p>表2. E与BMP-7对于糖尿病肾病的诊断效能</p><p>*差异具有统计学意义，P &lt; 0.05。</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>肾功能持续下降是糖尿病导致肾病发生发展的主要原因，这一过程伴有进行性肾间质损伤和肾纤维化等病理改变 [<xref ref-type="bibr" rid="hanspub.43351-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref8">8</xref>]。研究表明，骨形态发生蛋白-7 (BMP-7)可有效预防肾纤维化，是可用于辅助评估糖尿病肾病患者肾纤维化的有效标志物 [<xref ref-type="bibr" rid="hanspub.43351-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref10">10</xref>]。新兴的SWE技术应用于越来越多疾病的研究中 [<xref ref-type="bibr" rid="hanspub.43351-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref12">12</xref>]，本研究旨在探究E是否能作为评估糖尿病肾病疾病进展程度的指标，并对E与BMP-7的相关性进一步探讨。</p><p>根据免疫组化结果可知BMP-7主要沉积在近端小管和足细胞中。统计结果显示实验组中的BMP-7的表达含量随着病变严重而减少。出现此结果的原因可能与BMP-7拮抗转化生长因子的促纤维化过程密切相关。BMP-7通过增强基质转化而具有抗纤维化作用，以及逆转糖尿病引起的肾肥大，使肾小球滤过率、尿白蛋白排泄和肾小球组织学恢复正常，从而改善肾功能 [<xref ref-type="bibr" rid="hanspub.43351-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.43351-ref15">15</xref>]。故具有保护机制的BMP-7随着病情进展呈减低趋势。</p><p>研究结果提示正常白蛋白尿组患者的E与对照组的E差异无统计学意义(P &gt; 0.05)，可能因肾脏组织的病理改变并未达到临床可检测出的标准。与Betz [<xref ref-type="bibr" rid="hanspub.43351-ref16">16</xref>]、Samir [<xref ref-type="bibr" rid="hanspub.43351-ref17">17</xref>] 的统计结果一致，E随着肾组组病变的发展而增加，且E与BMP-7的相关性具有统计学意义(P &lt; 0.05)，呈负相关。原因可能为随着肾组织的进一步损伤，促纤维化因子逐渐增加，作为拮抗纤维化因子的BMP-7逐渐减少，导致肾组织纤维化程度也逐渐增加，肾组织的弹性降低，反之硬度升高，由于E的检出与被测组织的硬度相关，故此时E逐渐增加 [<xref ref-type="bibr" rid="hanspub.43351-ref18">18</xref>]。</p><p>ROC的结果表明，在预测E对照组与正常白蛋白尿组的截断值时不具有统计学意义，可能原因为正常白蛋白尿组肾组织并未明显受损，对于E的变化检出并不是很敏感。但是在早期白蛋白尿、临床白蛋白尿的预测中，E、BMP-7的截断值分别为4.9 kPa、5.8 kPa和172.3、114.1，这对临床检验具有提示性作用。通过ROC曲线结果可知，在预测早期白蛋白尿、临床白蛋白尿中，E、BMP-7的曲线下面积(AUC)分别为0.80、0.76和0.88、0.85，说明在糖尿病肾病的进程中，BMP-7较E值有更高的预测效益。产生这种结果的原因可能是BMP-7的减少可导致肾组织病变，而肾组织病变是导致E值的改变的原因，故BMP-7在诊断早期白蛋白尿、临床白蛋白尿具有更确切的意义，E值的诊断效能虽然不如BMP-7，但可以在临床中以一种非侵入性的手段对疾病进行预测。</p><p>肾活检是诊断肾组织病变 [<xref ref-type="bibr" rid="hanspub.43351-ref19">19</xref>] 的金标准。然而，操作过程繁琐，不仅需要麻醉并且会引起一些并发症。且肾活检最常见的并发症是出血。因此，在临床实践中，尤其是在糖尿病肾病的终末期等高危患者中，这种方法并不适用。故本研究对于SWE的应用进行了探究，发现SWE技术可用于评估肾实质硬度，且与糖尿病肾病患者的肾功能损害程度相关。本研究的局限性较多，需更多学者的研究，对SWE技术的优势进一步证实。</p></sec><sec id="s9"><title>文章引用</title><p>张 靓,宋 瓅,马蕾媛,邵长杰,于 宁. 杨氏模量值与BMP-7在糖尿病肾病不同分期诊断中的意义 Significance of Young’s Modulus and BMP-7 in the Diagnosis of Different Stages of Diabetic Nephropathy[J]. 临床医学进展, 2021, 11(06): 2781-2787. https://doi.org/10.12677/ACM.2021.116403</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.43351-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Tuttle, K.R., Bakris, G.L., Bilous, R.W., Chiang, J.L., de Boer, I.H., Goldstein-Fuchs, J., et al. (2014) Diabetic Kidney Disease: A Report from an ADA Consensus Conference. Diabetes Care, 37, 2864-2883.  
&lt;br&gt;https://doi.org/10.2337/dc14-1296</mixed-citation></ref><ref id="hanspub.43351-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., Long, J., Jiang, W., Shi, Y., He, X., Zhou, Z., et al. (2016) Trends in Chronic Kidney Disease in China. The New England Journal of Medicine, 375, 905-906. &lt;br&gt;https://doi.org/10.1056/NEJMc1602469</mixed-citation></ref><ref id="hanspub.43351-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ooxterhuis, N.R., Bongartz, L.G., Verhaar, M.C., Cheng, C., Xu, Y.J., van Koppen, A., et al. (2017) Targeting Multiple Pathways Reduces Renal and Cardiac Fibrosis in Rats with Subtotal Nephrectomy Followed by Coronary Ligation. Acta Physiologica, 220, 382-393. &lt;br&gt;https://doi.org/10.1111/apha.12829</mixed-citation></ref><ref id="hanspub.43351-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wang, B., Komers, R., Carew, R., Winbanks, C.E., Xu, B., Herman-Edelstein, M., et al. (2012) Suppression of MicroRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis. Journal of the American Society of Nephrology, 23, 252-265. &lt;br&gt;https://doi.org/10.1681/ASN.2011010055</mixed-citation></ref><ref id="hanspub.43351-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Greening, J. and Dilley, A. (2017) Posture-Induced Changes in Peripheral Nerve Stiffness Measured by Ultrasound Shear Wave Elastography. Muscle &amp; Nerve, 55, 213-222. &lt;br&gt;https://doi.org/10.1002/mus.25245</mixed-citation></ref><ref id="hanspub.43351-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Mansour, N., Hofauer, B. and Knopf, A. (2017) Ultrasound Elastography in Diffuse and Focal Parotid Gland Lesions. ORL: Journal for Otorhinolaryngology and Its Related Specialties, 79, 54-64. &lt;br&gt;https://doi.org/10.1159/000455727</mixed-citation></ref><ref id="hanspub.43351-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kang, H.M., Ahn, S.H., Choi, P., Ko, Y.-A., Han, S.H., Chinga, F., et al. (2015) Defective Fatty Acid Oxidationin Renal Tubular Epithelial Cells Has a Key Role in Kidney Fibrosis Development. Nature Medicine, 21, 37-46. 
&lt;br&gt;https://doi.org/10.1038/nm.3762</mixed-citation></ref><ref id="hanspub.43351-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sun, H.J. (2019) Current Opinion for Hypertension in Renal Fibrosis. In: Liu, B.C., Lan, H.Y. and Lv, L.L., Eds., Renal Fibrosis: Mechanisms and Therapies, Vol. 1165, Springer, Singapore, 37-47.  
&lt;br&gt;https://doi.org/10.1007/978-981-13-8871-2_3</mixed-citation></ref><ref id="hanspub.43351-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ikeda, Y., Jung, Y.O., Kim, H., Oda, T., López-Guisa, J., Maruvada, R., et al. (2004) Exogenous Bone Morphogenetic Protein-7 Fails to Attenuate Renal Fibrosis in Rats with Overload Proteinuria. Nephron Experimental Nephrology, 97, e123-e135. &lt;br&gt;https://doi.org/10.1159/000079177</mixed-citation></ref><ref id="hanspub.43351-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ohigashi, M., Imai, N., Toba, H., Kobara, M. and Nakata, T. (2016) Pitavastatin Exhibits Protective Effects on Podocytes Accompanied by BMP-7 Up-Regulation and Rho Suppression. Pharmacology, 97, 265-276.  
&lt;br&gt;https://doi.org/10.1159/000444397</mixed-citation></ref><ref id="hanspub.43351-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Sigrist, R.M.S., Joy, L., El Kaffas, A., Chammas, M.C. and Willmann, J.K. (2017) Ultrasound Elastography: Review of Techniques and Clinical Applications. Theranostics, 7, 1303-1329. &lt;br&gt;https://doi.org/10.7150/thno.18650</mixed-citation></ref><ref id="hanspub.43351-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chalasani, N., Younossi, Z., Lavine, J.E., Charlton, M., Cusi, K., Rinella, M., et al. (2018) The Diagnosisand Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 67, 328-357. &lt;br&gt;https://doi.org/10.1002/hep.29367</mixed-citation></ref><ref id="hanspub.43351-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Li, G., Li, Y., Liu, S., Shi, Y., Chi, Y., Liu, G., et al. (2013) Gremlin Aggravates Hyperglycemia-Induced Podocyte Injury by a TGF-β/Smad Dependent Signaling Pathway. Journal of Cellular Biochemistry, 114, 2101-2113.  
&lt;br&gt;https://doi.org/10.1002/jcb.24559</mixed-citation></ref><ref id="hanspub.43351-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Leeuwis, J.W., Nguyen, T.Q., Dendooven, A., Kok, R.J. and Goldschmeding, R. (2010) Targeting Podocyte-Associated Diseases. Advanced Drug Delivery Reviews, 62, 1325-1336. &lt;br&gt;https://doi.org/10.1016/j.addr.2010.08.012</mixed-citation></ref><ref id="hanspub.43351-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Qiao, X., Li, R.S., Li, H., Zhu, G.-Z., Huang, X.-G., Shao, S., et al. (2013) Intermedin Protects against Renalischemia-Eperfusion Injury by Inhibition of Oxidative Stress. American Journal of Physiology, 304, 112-119.  
&lt;br&gt;https://doi.org/10.1152/ajprenal.00054.2012</mixed-citation></ref><ref id="hanspub.43351-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Betz, B.B., Jenks, S.J., Cronshaw, A.D., Lamont, D.J., Cairns, C., Manning, J.R., et al. (2016) Urinary Peptidomics in a Rodent Model of Diabetic Nephropathy Highlights Epidermal Growth Factor as a Biomarker for Renal Deterioration in Patients with Type 2 Diabetes. Kidney International, 89, 1125-1135. &lt;br&gt;https://doi.org/10.1016/j.kint.2016.01.015</mixed-citation></ref><ref id="hanspub.43351-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Samir, A.E., Allegretti, A.S., Zhu, Q., Dhyani, M., Anvari, A., Sullivan, D.A., et al. (2015) Shear Wave Elastography in Chronic Kidney Disease: A Pilot Experience in Native Kidneys. BMC Nephrology, 16, Article No. 119. 
&lt;br&gt;https://doi.org/10.1186/s12882-015-0120-7</mixed-citation></ref><ref id="hanspub.43351-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Narmada, F., Shalini, W., Roshan, N., Rodrigo, C., Karunanayake, L., de Silva, H.J., et al. (2016) Protein Carbonyl as a Biomarker of Oxidative Stress in Severe Leptospirosis, and Its Usefulness in Differentiating Leptospirosis from Dengue Infections. PLoS ONE, 11, e0156085. &lt;br&gt;https://doi.org/10.1371/journal.pone.0156085</mixed-citation></ref><ref id="hanspub.43351-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Fiorentino, M., Bolignano, D., Tesar, V., Pisano, A., Van Biesen, W., D’Arrigo, G., et al. (2016) Renal Biopsy in 2015: From Epidemiology to Evidence-Based Indications. American Journal of Nephrology, 43, 1-19.  
&lt;br&gt;https://doi.org/10.1159/000444026</mixed-citation></ref></ref-list></back></article>